Aberrant expression of m6A methyltransferase METTL3 has been reported with oncogenic role in various cancer types, including pancreatic cancer [32], bladder cancer [33], liver cancer [34], and acute myeloid leukemia [35]. This evidence concerns the gene METTL3 and urinary bladder cancer.